The Journal of Pediatrics
Volume 151, Issue 3 , Pages 266-270.e1 , September 2007

Nebulized Hypertonic Saline in the Treatment of Viral Bronchiolitis in Infants

  • Brian A. Kuzik, MD, MSc, FRCP(C)

      Affiliations

    • Department of Paediatrics, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
    • Corresponding Author InformationReprint requests: Brian A. Kuzik, MD, MSc, FRCP(C), Department of Paediatrics, Royal Victoria Hospital of Barrie, 208-1 Quarry Ridge Road, Barrie, Ontario, Canada L4M 6M2.
    • ,
  • Samim A. Al Qadhi, MD, MBChB

      Affiliations

    • Department of Paediatrics, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
    • ,
  • Steven Kent, BSc(med), MD, FRCP(C)

      Affiliations

    • Department of Paediatrics, University of British Columbia, Victoria General Hospital, Victoria, British Columbia, Canada
    • ,
  • Michael P. Flavin, MB, MRCP(UK), FRCP(C)

      Affiliations

    • Department of Paediatrics, Queen’s University, Kingston General Hospital, Kingston, Ontario, Canada
    • ,
  • Wilma Hopman, MA

      Affiliations

    • Clinical Research Unit, Kingston General Hospital, Kingston, Ontario, Canada.
    • ,
  • Simon Hotte, MD

      Affiliations

    • Department of Paediatrics, Queen’s University, Kingston General Hospital, Kingston, Ontario, Canada
    • ,
  • Sarah Gander, MD

      Affiliations

    • Department of Paediatrics, Queen’s University, Kingston General Hospital, Kingston, Ontario, Canada

Received 17 August 2006 ,Revised 7 March 2007 ,Accepted 9 April 2007.

References 

  1. Gleazen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med. 1973;288:498–505
  2. Ray CG, Minnich LL, Holberg CJ, Shehad ZM, Wright AL, Barton LL, et al. Respiratory syncytial virus–associated lower respiratory illnesses: possible influence of other agents. Pediatr Infect Dis. 1993;12:15–19
  3. Smyth RL, Openshaw PJM. Bronchiolitis. Lancet. 2006;368:312–322
  4. Hall CB. RSV and parainfluenza virus. N Engl J Med. 2001;344:1917–1928
  5. McConnochie KM, Roghmann KJ, Liptak GS. Hospitalization for lower respiratory tract illness in infants: variation in rates among counties in New York State and areas within Monroe Counties. J Pediatr. 1995;126:220–229
  6. Pelletier AJ, Mansbach JM, Camargo CA. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006;118:2418–2423
  7. Wright RB, Pomerantz WJ, Luria JW. New approaches to respiratory infections in children: bronchiolitis and croup. Emer Med Clin North Am. 2002;20:93–114
  8. Subcommittee on Diagnosis and Management of BronchiolitisAmerican Academy of Pediatrics. Diagnosis and management of bronchiolitis. Pediatrics. 2006;118:1774–1793
  9. Welliver JR, Welliver RC. Bronchiolitis. Pediatr Rev. 1993;14:134–139
  10. Aherne W, Bird T, Court SDM, Gardner PS, McQuillin J. Pathological changes in viral infections of the lower respiratory tract in children. J Clin Pathol. 1970;23:7–18
  11. Kostagal UR, Robbins JM, Kini NM, Schoettker PJ, Atherton HD, Kirschbaum MS. Impact of a bronchiolitis guideline: a multi-site demonstration project. Chest. 2002;121:1789–1797
  12. Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics. 2005;115:878–884
  13. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Efficacy of bronchodilator therapy in bronchiolitis: a meta-analysis. Arch Pediatr Adolesc Med. 1996;150:1166–1172
  14. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2000;CD001266
  15. Flores G, Horwitz RI. Efficacy of beta-2 agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics. 1997;100:233–239
  16. Schuh S, Coates AL, Binnie R, Allin T, Goia C, Corey M, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr. 2002;140:27–32
  17. Csonka P, Kaila M, Laippala P, Iso-Mustajarvi M, Vesikari T, Ashorn P. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr. 2003;143:725–730
  18. Weinberger M. Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection–induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr. 2004;145:137–138
  19. Patel H, Platt R, Lozano JM, Wang EEL. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev. 2004;CD004878
  20. Bulow SM, Nir M, Levin E, Friis B, Thomsen LL, Nielsen JE, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics. 1999;104:e77
  21. van Woensel JB. Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus. Pediatr Pulmonol. 2000;30:92–96
  22. King VJ, Viswanathan M, Bordley C, Jackman AM, Sutton SF, Lohr KN, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004;158:127–137
  23. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006;354:229–240
  24. Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol. 1996;21:77–83
  25. Riedler J, Reade T, Button B, Robertson CF. Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis. J Paediatr Child Health. 1996;32:48–50
  26. Suri R, Grieve R, Normand C, Metcalfe C, Thompson S, Wallis C, et al. Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcome in children with cystic fibrosis. Thorax. 2002;57:841–846
  27. Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax. 1997;52:900–903
  28. Tomooka LT, Murphy C, Davidson TM. Clinical study and literature review of nasal irrigation. Laryngoscope. 2000;110:1189–1193
  29. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalizations stay: 2 years experience. IMAJ. 2006;8:169–173
  30. Sarrell E, Tal G, Witzling M, Someck E, Houri S, Cohen HA, et al. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest. 2002;122:2015–2020
  31. Wainright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D, et al. A multicentre, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med. 2003;349:27–35
  32. Patel H, Platt RW, Pekeles GS, Ducharme FM. A randomized controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuteral and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr. 2002;141:818–824
  33. Ray MS. Comparison of nebulized adrenaline versus salbutamol in wheeze associated with respiratory tract infection in infants. Indian Pediatr. 2002;39:12–22
  34. Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics. 1987;79:939–945
  35. Cheney J, Barber S, Altamirano L, Cheney M, Williams C, Jackson M, et al. A clinical pathway for bronchiolitis is effective in reducing readmission rates. J Pediatr. 2005;147:622–626
  36. Todd J, Bertock D, Dolan S. Use of a large national database for comparative evaluation of the effect of a bronchiolitis/viral pneumonia clinical care guidelines on patient outcome and resource utilization. Arch Pediatr Adolesc Med. 2002;156:1086–1090
  37. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr. 1995;126:1004–1007
  38. Cataldo D, Foidant JM, Lau L, Bartsch P, Djukanovic R, Louis R. Induced sputum: comparison between isotonic and hypertonic saline solution in patients with asthma. Chest. 2001;120:1815–1821
  39. Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with bronchiolitis. Chest. 2003;123:481–487
  40. Araki H. Inhalation of hypertonic saline as a bronchial challenge in children with mild asthma and normal children. J Allergy Clin Immunol. 1989;84:99–107
  41. Williams PV. Inhalation bronchoprovocation in children. Immunol Clin North Am. 1998;18:149–164
  42. Suri R, Marchall LJ, Wallis C, Mecalfe C, Shute JK, Bush A. Safety and use of sputum induction in children with cystic fibrosis. Pediatr Pulmonol. 2003;35:309–313
  43. Friedman SM. The inflation calculator. Available at http://www.westegg.com/inflation/.

 Supported by the Queen Alexandra Foundation for Children, British Columbia, Canada; Vancouver Island Health Authority, Youth and Maternal Programme, British Columbia, Canada; and an Ontario Thoracic Society block term grant.

 No reprint requests are available from the authors.

PII: S0022-3476(07)00345-9

doi: 10.1016/j.jpeds.2007.04.010

The Journal of Pediatrics
Volume 151, Issue 3 , Pages 266-270.e1 , September 2007

Article Tools

* Image Usage & Resolution